Ensuring Research Integrity - Research, Development, and Demonstration

The summary for the Ensuring Research Integrity - Research, Development, and Demonstration grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Office of the Assistant Secretary for Health, which is the U.S. government agency offering this grant.

Ensuring Research Integrity - Research, Development, and Demonstration: The Office of Research Integrity (ORI) announces the anticipated availability of funds for Fiscal Year (FY) 2023 grant awards under the authority of Sec. 301 of the Public Health Service Act, 42 U.S.C. § 241. ORI seeks projects that will: 1) conduct research, on one of the four focus areas identified below, related to ensuring research integrity and compliance with 42 C.F.R. Part 93; 2) develop innovative approaches/tools/resources based on the results of this research; and 3) demonstrate the impact and/or effectiveness of these approaches/tools/resources. The purpose of this initiative is to provide assistance to recipients to promote the integrity and reliability of PHS-funded research through the development and implementation of innovative practical approaches/tools/resources that improve practices related to one of the following four focus areas: 1) transparency in the reporting of research; 2) effective communication between authors/collaborators for the purpose of avoiding, mitigating, and resolving authorship/collaborator disputes and/or issues related to the integrity of the research (e.g. conflicts of interest, research integrity, rigor, reproducibility, transparency, reliability); 3) handling allegations of research misconduct under 42 C.F.R. Part 93; or 4) interventions to address issues related to research culture and climate (e.g., ultra-competitive environments, toxic workplaces, bullying, harassment, etc.) that can negatively impact the integrity, conduct, quality, and reliability of research. ORI expects that approaches/tools/resources developed through this funding opportunity will be disseminated to and made freely available for use by the PHS-funded research community. This funding opportunity does not support projects with the primary purpose of holding meetings, conferences, or workshops (see opportunity IR-ORI-23-002). ORI anticipates making awards of between $75,000 and $150,000 in total federal share (direct plus indirect) per year, for a project period not to exceed two years (two 12-month budget periods). Recipients will be required to submit a non-competing application for any budget period after the first. (Budget periods are typically 12 months). Continuation award funding will be contingent upon availability of funding, satisfactory performance (including awardee progress towards meeting stated project milestones goals, timely submission of required reports, and compliance with all grant terms and conditions), and the best interests of the government.